Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rong Mu

Showing results (221-230 of 233) with videos related to

Pageof 24
Sort By:
Journal of Evidence-Based Medicine|December 18, 2025
Patient Version of Guideline for Fibromyalgia (2025 Edition)Zhiling Zhang, Pengxiang Zhou, Na He, et al.
JAMA Network Open|November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical TrialJing He, Jiali Chen, Miao Miao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
International Journal of Rheumatic Diseases|October 23, 2018
Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional studyYunshan Zhou, Xiuru Wang, Yuan An, et al.
RMD Open|July 10, 2021
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditAnne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
Rheumatology (Oxford, England)|March 25, 2015
The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional studyXiaoying Zhang, Rong Mu, Xiuru Wang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2012
[Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study]Tian Liu, Xiu-ru Wang, Yuan An, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2012
[Survey of tumor necrosis factor inhibitors application in patients with rheumatoid arthritis in China]Xiu-ru Wang, Yin Su, Yuan An, et al.
Clinical Rheumatology|March 26, 2017
Cardiovascular disease in rheumatoid arthritis: medications and risk factors in ChinaChun Li, X R Wang, H J Ji, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in EuropeansLei Jiang, Jian Yin, Lingying Ye, et al.
Pageof 24

Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Journal of Evidence-Based Medicine|December 18, 2025
Patient Version of Guideline for Fibromyalgia (2025 Edition)Zhiling Zhang, Pengxiang Zhou, Na He, et al.
JAMA Network Open|November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical TrialJing He, Jiali Chen, Miao Miao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
International Journal of Rheumatic Diseases|October 23, 2018
Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional studyYunshan Zhou, Xiuru Wang, Yuan An, et al.
RMD Open|July 10, 2021
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditAnne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
Rheumatology (Oxford, England)|March 25, 2015
The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional studyXiaoying Zhang, Rong Mu, Xiuru Wang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2012
[Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study]Tian Liu, Xiu-ru Wang, Yuan An, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2012
[Survey of tumor necrosis factor inhibitors application in patients with rheumatoid arthritis in China]Xiu-ru Wang, Yin Su, Yuan An, et al.
Clinical Rheumatology|March 26, 2017
Cardiovascular disease in rheumatoid arthritis: medications and risk factors in ChinaChun Li, X R Wang, H J Ji, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in EuropeansLei Jiang, Jian Yin, Lingying Ye, et al.
Pageof 24